The iconic rise of Viagra has firmly established as a benchmark of pharmaceutical success, yet its legacy within the broader market now raises questions about long-term returns . Generic versions are diminishing market share, causing worries that investing in companies closely tied to Viagra's former position could be a dangerous decision , especia